ArticleJournal of gastroenterology2023
Correction: Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.
Abstract readPublished Erratum
In one paragraph
Article in Journal of gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
20 authors.
Shin FukudoGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan. sfukudo@med.tohoku.ac.jp.ORCID http://orcid.org/0000-0003-2265-0349
Toshikatsu OkumuraGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Masahiko InamoriGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Yusuke OkuyamaGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Motoyori KanazawaGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Takeshi KamiyaGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Ken SatoGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Akiko ShiotaniGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Yuji NaitoGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Yoshiko FujikawaGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Ryota HokariGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Tatsuhiro MasaokaGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Kazuma FujimotoGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Hiroshi KanekoGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Akira ToriiGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Kei MatsuedaGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Hiroto MiwaGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Nobuyuki EnomotoGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Tooru ShimosegawaGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Kazuhiko KoikeGuidelines Committee for Creating and Evaluating the "Evidence-Based Clinical Practice Guidelines for Irritable Bowel Syndrome", The Japanese Society of Gastroenterology, 6F Shimbashi I-MARK Building, 2-6-2 Shimbashi, Minato-Ku, Tokyo, 105-0004, Japan.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.